Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the 37th Annual Report for the Financial Year 2024-2025 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 3.6 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shree Pacetronix Ltd has filed its 37th Annual Report for FY 2024-2025 with BSE, along with the notice for its 37th Annual General Meeting scheduled for September 3, 2025, to be held via video conferencing. Key business items up for shareholder approval include re-appointment of Mr. Atul Kumar Sethi as Managing Director for another 3-year term (till November 2028), and appointment of Mrs. Shraddha Jain as Secretarial Auditor for 5 years. The company also seeks approval for a preferential issue of 75,150 equity shares to promoter Mr. Akash Sethi at ₹81 per share (aggregating ₹60.87 lakhs) and 2,25,450 convertible warrants to the same allottee at ₹81 per warrant (aggregating ₹1.83 crores), with 25% upfront payment and 18-month conversion window. The AGM will use CDSL's e-voting platform for remote voting and voting during the meeting.
The preferential allotments to promoter Mr. Akash Sethi will dilute existing shareholders modestly while increasing the promoter's stake and bringing in ~₹45.65 lakhs of upfront warrant money plus ₹60.87 lakhs from the share issue. The re-appointment of the existing MD provides continuity in leadership.